Teva’s Ajovy yields positive data in post-hoc migraine analysis

Teva’s Ajovy yields positive data in post-hoc migraine analysis

Submitted by admin on December 6, 2023 - 10:20am
Source: 
Clinical Trials Arena
News Tags: 
Teva Pharmaceutical
Ajovy
obesity
migraines
post-hoc analysis
Headline: 
Teva’s Ajovy yields positive data in post-hoc migraine analysis
snippet: 

Post-hoc analysis of two Phase III studies demonstrated that the safety and efficacy of Ajovy were the same in patients with obesity compared to normal-BMI patients.

Do Not Allow Advertisers to Use My Personal information